On March 25, 2025, the U.S. Food and Drug Administration (FDA) approved Blujepa, a novel antibiotic developed by GlaxoSmithKline (GSK), for the treatment of uncomplicated urinary tract infections (UTIs) in …
Tag:
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More